DermTech Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. DermTech prevailing Real Value cannot be determined due to lack of data. The current price of DermTech is $0.0. Our model computes the value of DermTech from reviewing the firm fundamentals such as Shares Owned By Insiders of 2.62 %, operating margin of (5.33) %, and Shares Outstanding of 34.96 M as well as analyzing its technical indicators and probability of bankruptcy.
DermTech Total Value Analysis
DermTech is currently anticipated to have valuation of 15.43 M with market capitalization of 3.29 M, debt of 54.39 M, and cash on hands of 173.79 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the DermTech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.43 M | 3.29 M | 54.39 M | 173.79 M |
DermTech Investor Information
About 18.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. DermTech recorded a loss per share of 2.65. The entity last dividend was issued on the 30th of August 2019. The firm had 1:2 split on the 30th of August 2019. DermTech is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.DermTech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DermTech has an asset utilization ratio of 12.54 percent. This suggests that the Company is making $0.13 for each dollar of assets. An increasing asset utilization means that DermTech is more efficient with each dollar of assets it utilizes for everyday operations.DermTech Ownership Allocation
DermTech holds a total of 34.96 Million outstanding shares. Roughly 79.29 percent of DermTech outstanding shares are held by general public with 2.62 (percent) owned by insiders and only 18.09 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.DermTech Profitability Analysis
The company reported the previous year's revenue of 15.3 M. Net Loss for the year was (100.89 M) with profit before overhead, payroll, taxes, and interest of 647 K.DermTech Growth Indicators
Investing in growth stocks can be very risky. If the company such as DermTech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 32.6 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in DermTech Stock
If you are still planning to invest in DermTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DermTech's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |